Iron is essential for the growth of animals, plants, and most microorganisms. However, in aerobic organisms, iron poses problems of cytotoxicity and bioavailability. This is because it reacts with oxygen to generate toxic free radicals and because it is relatively insoluble in its oxidized state. Many bacteria overcome the latter problem by elaborating specific Fe3" uptake mechanisms involving extracellular chelators or siderophores (26) and by depositing iron stores. These iron stores allow growth in iron-deficient medium (21) , and their deposition may also provide a means of iron detoxification. Part of the stored iron is associated with bacterioferritin (BFR) (4), a protein that has been detected in at least seven bacterial species (3, 7, 14, 23, 24, 36, 44) .
BFR is similar in many respects to ferritin, the wellcharacterized iron storage molecule of animals (9, 38) and plants (17, 30) . Electron microscopy and X-ray diffraction data indicate that the BFR of Escherichia coli has a quaternary structure resembling that of horse spleen ferritin (30a, 30b, 44) . It comprises an iron core (diameter, approximately 6 nm) surrounded by a roughly spherical protein shell (external diameter, approximately 12 nm) which is composed of 24 structurally identical subunits arranged in 4-3-2 symmetry (30b) . The subunit molecular weight of the BFR from E. coli has been estimated as 15,000.(44) or 18,000 (31) , and a molecular weight of approximately 500,000 has been obtained for the 24 -mer holoprotein (43) . These values are similar to those reported for plant and animal ferritins (17, 30, 38) .
The polynuclear iron core of BFR may contain from 0 to approximately 3,000 iron atoms per molecule in the form of structurally amorphous oxyhydroxide-ferric phosphate (19, 20) . However, reconstitution of the BFR iron core in vitro, without phosphate, produces a more highly ordered (ferrihydrite) core structure as found for the iron cores of mammalian ferritins (20) .
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Unlike animal and plant ferritins, BFR is a hemoferritin containing protoheme IX: one heme per two subunits in the Azotobacter vinelandii and E. coli proteins (36; J. Yariv, personal communication) and one heme per five subunits in the Pseudomonas aeruginosa protein (24) . The BFRs of E. coli and A. vinelandii are known to be identical to the proteins previously designated cytochromes b1 and b557.5, respectively (31, 36, 43) . Antiserum raised against BFR from Azotobacter chroococcum shows no reactivity with horse spleen ferritin, but it exhibits partial reactivity with phytoferritin (7) , and there is also good reactivity between anti-E. coli BFR and the A. vinelandii protein (Yariv, personal communication) . There is no similarity between the peptide sequences of the BFR of E. coli (39) and the sequences of mammalian ferritins, despite their structural and functional relationships.
This paper describes the molecular cloning, nucleotide sequence, and map position of the bacterioferritin gene (bfr) of E. coli, and it also provides the first primary structure of a bacterioferritin from any source. In a recent short communication this primary structure was compared with previous N-terminal sequence data and amino acid compositions for BFR, and structural similarities with mammalian ferritins were also predicted (1) .
MATERIALS AND METHODS
Bacterial strains, plasmids, and bacteriophage. Strains of E. coli K-12 were used as follows: JM101 [thi supE A(proABlac) F' traD36 proA+B+ lacIqZAM15], as host for M13 and pUC derivatives (22) , and C600, as host for recombinant A phages. The phagemid vector pUC119 (40) in L-broth plus ampicillin (50 ,ug ml-') where appropriate.
Bacteriophage and plasmid DNAs were isolated and manipulated as described previously (11, 18) .
Immunochemical detection of BFR and X bfr. Antiserum raised in goat against BFR purified from E. coli K-12 strain 3300 was kindly supplied by J. Yariv Fig. 4 ). Single-stranded M13 templates were sequenced by the chain-termination method using two "universal" primers, [(X-355]thio-dATP, buffer gradient gels, and Sequenase (5, 28, 37) . The amount of sequence obtained with some of the clones was increased by using specific oligonucleotide primers designed on the basis of the initial sequences. Oligonucleotides were made with an Applied Biosystems 381A DNA Synthesizer. Nucleotide sequences were compiled and analyzed with the aid of Staden computer programs (34, 35 
RESULTS
The initial strategy used for cloning the bfr gene of E. coli was based on information in the gene-protein index of Neidhardt et al. (25) , which indicated that BFR is expressed by plasmids pLC25-14 and pLC46-7 containing inserts from the 53-and 83-min regions of the linkage map, respectively. These plasmids were both found to contain overlapping segments of bacterial DNA from the 53-min region, and they expressed a polypeptide that comigrated with BFR in twodimensional electrophoretic gels. However, it was clear from the nucleotide sequence of the corresponding gene that its product differed from BFR in both N-terminal sequence and amino acid composition (1, 39) . A second strategy, using oligonucleotide probes based on segments of the partial BFR sequence published by Tsugita and Yariv (39) , also failed, but it is now apparent that the partial sequence differs considerably from a more recent N-terminal sequence (1) and the gene-derived sequence. The third and successful strategy involved the immunochemical screening procedure described below.
Cloning of a bfr-A hybrid gene. Immunoscreening of a XPE11-E. coli gene bank with anti-BFR antiserum yielded five immunopositive clones: four with identical inserts (XG207 through -210) and one (XG206) having a unique and apparently unrelated insert (Fig. 1) containing the inserts cloned in XG206 and XG210 and various subfragments thereof, were constructed and designated pGS271 to -277 (Fig. 1) . Cultures of JM101 transformants containing each of the plasmids were analyzed by Western blotting after SDS-PAGE. Each contained an immunoreactive band (Mr 18,500) corresponding to the BFR subunit of the host ( Fig. 2A ). An additional immunoreactive band (Mr 21,000) was observed with the pGS275 and pGS277 transformants, and this was particularly well expressed with pGS277. All of the strains exhibited a prominent band of Mr 23,000, but subsequent tests showed that its appearance was not dependent upon the presence of the anti-BFR serum. This band reacted directly with the streptavidin-biotin complex and may therefore represent the biotin carboxyl carrier protein (Mr 22,500) of the acetyl coenzyme A carboxylase complex, the sole biotin-containing protein found in E. coli (41) . In parallel SDS-PAGE analyses of total cell protein, a polypeptide corresponding to the unique immunoreactive (Fig. 2B) . Soluble extracts were also examined, using nondenaturing conditions to prevent dissociation of the BFR 24-mer (Mr approximately 500,000), and a protein having the corresponding mobility was detected in the pGS277-transformed strain, but not in the host (Fig. 3) . Two proteins of much lower mobility which could correspond to larger BFR-like complexes were also detected in the pGS277-transformed strains. These observations, together with the proximity of the active segment of bacterial DNA to the flanking segment of X DNA, suggested that a BFR-A fusion protein was being expressed from a bfr-X hybrid gene in XG206, pGS275, and pGS277. Partial sequence of the bfr gene. The plasmids pGS275 and pGS277 share a common 1.4-kilobase (kb) EcoRI-HindIII fragment (R2 to HV2 in Fig. 1 20 ,077. This is only slightly smaller than the value (21,000) estimated for the bfr-A hybrid gene product by SDS-PAGE (Fig. 2) .
To obtain the entire bfr gene, its position was located in the physical map of the E. coli chromosome by hybridization and the gene was then cloned from the corresponding phage in the A-E. coli gene bank of Kohara et al. (15) .
Location of the bfr gene in the physical map of the E. coli chromosome. Identical Southern blots containing seven restriction digests of E. coli W3110 DNA were probed with M13mpl8 and with a derivative (M13mpl8-bfrDX) contain- Fig. 1 , except for DraI (D) and Pstl (P). The relative positions and polarities of the str, S10, spc . and a operons at 73 min in the E. coli physical map (15, 27) AATGATGTGGAGTATCATGAATCCATTGATGAGATGAAACACGCCGATCGTTATATTGAGCGCATTCTTTTTCTGGAAGGTCTTCCAAAC   640  650  660  670  680  690  700  710  720   80 90 100 ing the 367-bp DraI-XhoII fragment which includes 122 bfr hybridizing fragments. The fragments hybridizing with the codons (Fig. 5) . The probes were labeled by a random M13mpl8 probe closely matched the pattern predicted for priming procedure using a nonradioactive but immunochemthe physical map of the lac region (15) . The pattern observed ically detectable precursor, and DNA standards labeled with with the M13mpl8-bfrDX probe contained the same lac the same precursor were used for estimating the size of fragments plus an additional set of fragments corresponding (Fig. 5) . The other potential coding region (gen-24') extends Ps into the sequenced region for just 24 codons, and it presum-
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ably specifies the C terminus of a larger polypeptide (gp24'). to a unique region of the E. coli physical map at 73 min (Fig.  6) .
The inferred position of the bfr gene was confirmed by probing a "mini-set" of 476 X clones containing the entire E. coli chromosome (15) . Plaques from only one clone, O9H3, hybridized uniquely with the M13mpl8-bfrDX probe. This phage contains the region identified by Southern blotting (Fig. 6) , and the results confirmed that the bfr gene is located at 73 min in the E. coli linkage map. A Southern blot analysis of the four BFR-immunopositive phages (XG207 through -210) failed to show any hybridization with the M13mpl8-bfrDX probe, and the reason for their initial selection remains obscure.
Cloning of the intact bfr gene. The bfr gene of X9H3 was subcloned into pUC119 on a 4.9-kb EcoRI-HindIII fragment (R2 to H) to generate pGS280 (Fig. 4) . A 3-kb fragment of bacterial DNA (P1 to P3) was removed by PstI-mediated deletion and religation to generate pGS281 (Fig. 4 ). An examination of the total cell proteins of JM101 derivatives transformed with pGS280 and pGS281, or infected with M13mpl8 carrying the bfr region (R2 to P1), indicated that an immunostaining band corresponding to BFR is very considerably amplified in Western blots of SDS-PAGE-fractionated samples (data not shown). Quantitative estimates from Coomassie Blue-stained SDS-PAGE tracks of the pGS281 transformants indicated that BFR represents 14 to 15% of the total cell protein (Fig. 2B ) and the soluble protein (not shown). Native PAGE analysis of soluble extracts of the pGS281 transformant also showed that the BFR 24-mer (and possibly higher oligomers) is amplified relative to the host, where the corresponding band(s) is not visible (Fig. 3) . These results confirm that an intact bfr gene has been cloned in the 1.55-kb insert of pGS281.
Complete nucleotide sequence of the bfr gene and an unidentified gene (gen-64). The partial sequence of the bfr gene obtained with pGS277 was overlapped and extended using clones derived from pGS280 (Fig. 4) . The complete sequence is contained in the 1,350-bp segment shown in Fig. 5 (1) . There are five histidine and seven methionine residues which could function as heme ligands, and secondary-structure predictions suggest that the BFR molecule could consist of a bundle of four antiparallel cx-helices resembling mammalian ferritins and several bacterial cytochromes (1) . The bfr gene is highly expressed in pGS281 transformants which, according to quantitative SDS-PAGE, represent an excellent source of BFR. The high amplification of BFR apparent in denatured samples (14 to 15%) contrasts with estimates of approximately 1% obtained under nondenaturing conditions. It is possible that the assembly of most of the BFR is incomplete or that it forms aggregates or membrane-bound complexes that are excluded from native gels. The hybrid BFR-A protein expressed from pGS277 appears to assemble into a 24-mer of comparable mobility to BFR, despite the presence of 14 extra C-terminal residues. The C terminus must be located in such a position that it can be extended without gross disruption of the structure, possibly by protruding into the central cavity of BFR.
The bfr gene is preceded by a putative ribosome binding site and a good potential promoter (P3) in the relatively short (70-bp) intergenic region (Fig. 5) . The bfr promoter region contains a partially palindromic sequence which may function as an operator because it overlaps the proposed -10 sequence and the transcriptional start site (Fig. 5) . There is also a G+C-rich region of hyphenated dyad symmetry (AG = -96 kJ mol-') immediately downstream of the bfr coding region (Fig. 5 ). This could function as a transcriptional terminator although it lacks the run of T(U) nucleotides which is typically associated with rho-independent terminators. The codon preferences suggest that bfr is a weakly or moderately expressed gene because it exhibits a relatively high proportion of modulatory codons (3.2%) and a low proportion of optimal energy codons (40%) in the diagnostic set (10) .
The expression of mammalian ferritins is induced by iron (45) , but this has not been investigated for BFRs. The expression of a number of E. coli genes concerned with iron uptake is known to be modulated by iron, and in many cases this is mediated by the regulatory protein Fur (12) . A Fur-Fe2+ complex is thought to bind to a 19-bp recognition site known as the iron box in the operator regions of the regulated genes (8) . An (Fig. 5) . Furthermore, this sequence is associated with a potential promoter sequence of opposite polarity to the bfr gene (Fig. 5) . It is therefore conceivable that this promoter expresses an antisense mRNA that could base-pair with the bfr transcript, and thus repression of the antisense promoter by the FurFe2+ complex would lead indirectly to derepression of the bfr gene by iron. No binding site for the cyclic AMP receptor protein (CRP) (6) or the anaerobic gene regulator (FNR) (33), was detected.
The unidentified gene, gen-64, encodes a product of average hydropathy and relatively high content of basic amino acids. The gen-64 coding region is preceded by a putative ribosome binding site, and its codon usage is typical of a moderately expressed gene. There are two potential promoter sequences upstream of gen-64 and no obvious transcriptional terminator, which raises the possibility that gen-64 and bfr are cotranscribed (Fig. 5) . The function of gp64 remains unknown, and computer searches of several data bases revealed no significant homologies with gp64 (or BFR). The C-terminal end of the second unidentified gene (gen-24') gives no clues about its function, but it is immediately followed by a region that would generate a transcript of potentially complex secondary structure and by an unusually A+T-rich region (80% A+T for the 143 to 233 segment) (Fig.  5) .
It has recently been reported that E. coli contains two novel iron proteins (B. F. Matzanke, G. I. Muller, E. Bill, G. Winkelmann, and A. X. Trautwein, Abstr. Sites Actifs Metalliques en Biologie et Analoges Synthdtiques II, 1988, p. 35). However, the precise functions of these proteins in bacterial ferrometabolism and their relationship to BFR have yet to be established. Indeed, relatively little is known about the intracellular metabolism of iron in bacteria compared with our understanding of its uptake. The cloning, mapping, and overexpression of the bfr gene will facilitate various studies including the isolation and physiological characterization of bfr mutants, which should help to redress this imbalance.
